/Investor DB

Band of Angels — 2014 Investments

6 investments dated 2014 · listed companies and verified rows first · show all

Ginkgo Bioworksginkgo.bioin𝕏NYSE: DNAJul 2014

Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.

AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US

Jason Kelly(Founder)inReshma Shetty(Founder)inBarry Canton(Founder)inAustin Che(Founder)inTom Knight(Founder)inBartholomew Canton(Executive Officer)

Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+62 more

Ciel Medicalcielmedical.cominFeb 2014

BiotechHealthtechSan Carlos, US

Mary Katherine Garrett(Executive Officer, Director)

BoardJay Watkins(Director)inDan Azagury(Director)inKate Garrett(Executive Officer, Director)inBeverly Huss(Director)

Co-investorsAstiaSonder Capital

Limeadelimeade.comOct 2014

Bellevue, US

HENRY ALBRECHT(Executive Officer, Director)Erick Rivas(Founder)inCHRISTOPHER DICKINSON(Executive Officer)JEFF DIRKS(Executive Officer)

BoardSTEVE HAMERSLAG(Director)CHRIS ACKERLEY(Director)

Co-investorsAtlas AcceleratorOak HC/FTTVC Capital

NuGEN TechnologiesinSep 2014

HealthtechSan Carlos, US

Nurith Kurn(Executive Officer, Director)inElizabeth Hutt(Executive Officer, Director)inDan Benetz(Executive Officer)in

BoardJeff Bird(Director)James Wilson(Director)Mike Hunkapiller(Director)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ArrayentForensic Logic

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.